ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Study of BHV-1300 in Graves' Disease

ClinicalTrials.gov ID: NCT06980649

Public ClinicalTrials.gov record NCT06980649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Biomarker Study of BHV-1300 in Graves' Disease

Study identification

NCT ID
NCT06980649
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Biohaven Therapeutics Ltd.
Industry
Enrollment
15 participants

Conditions and interventions

Conditions

Interventions

  • BHV-1300 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 20, 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027
Last update posted
May 17, 2026

2025 – 2027

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Site-103 South Gate California 90280 Recruiting
Site-100 Miami Florida 33126 Recruiting
Site-104 Columbus Georgia 31904 Recruiting
Site-108 Greenville North Carolina 27834 Recruiting
Site-110 Canton Ohio 44718 Recruiting
Site-107 Memphis Tennessee 38119 Recruiting
Site-109 Dallas Texas 75246 Not yet recruiting
Site-106 Houston Texas 77054 Recruiting
Site-101 Houston Texas 77095 Recruiting
Site-105 Shavano Park Texas 78231 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06980649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06980649 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →